19 results
S-8
EX-5.1
SLRN
Acelyrin Inc
28 Mar 24
Registration of securities for employees
4:43pm
are applicable to the subject matter hereof and express no opinion and provide no assurance as to compliance with any federal or state securities law, rule
10-K
2023 FY
SLRN
Acelyrin Inc
28 Mar 24
Annual report
4:21pm
or license any issued patents with claims directed to SLRN-517 and there can be no assurance that we will obtain any issued patents directed to SLRN-517 … .
The patent positions of biotechnology companies are complex and uncertain. There can be no assurance that our patents, even once issued, will be held
10-K
2023 FY
EX-4.3
SLRN
Acelyrin Inc
28 Mar 24
Annual report
4:21pm
provisions, and there can be no assurance that such provisions will be enforced by a court in those other jurisdictions. We note that investors cannot
10-Q
2h27np
15 Jun 23
Quarterly report
4:19pm
8-K
EX-3.2
wce gax7wf45ti4j2
9 May 23
ACELYRIN, INC. Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
4:16pm
S-8
EX-5.1
0k6nm26s 8jw
8 May 23
Registration of securities for employees
5:27pm
424B4
thrd7ceab
5 May 23
Prospectus supplement with pricing info
4:22pm
S-1MEF
EX-5.1
yro9vxhzdk
4 May 23
Registration of additional securities for an S-1
5:55pm
S-1/A
r8fw5z5p
1 May 23
IPO registration (amended)
6:10am
S-1/A
EX-3.4
az4up
1 May 23
IPO registration (amended)
6:10am
S-1/A
EX-5.1
w0rd8sboq pp5kry7
1 May 23
IPO registration (amended)
6:10am
S-1/A
EX-1.1
za15o8 pv5f
1 May 23
IPO registration (amended)
6:10am
S-1
4xa26y35xheao4 2hgb
13 Apr 23
IPO registration
5:10pm
S-1
EX-10.12
bxiin38ibj
13 Apr 23
IPO registration
5:10pm
- Prev
- 1
- Next